 CARLSBAD, Calif., Feb. 18, 2022 GLOBE NEWSWIRE -- Palisade Bio, Inc. Nasdaq: PALI, a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal GI complications, will present at the Biocom Global Life Science Partnering Conference in San Diego on Thursday, February 24, 2022. Palisade Bios Chief Executive Officer, Tom Hallam, Ph.D., is scheduled to present an updated presentation at 11:30 a.m. Pacific Time. Palisade Bios presentation can be accessed at on our website at 